1. Home
  2. IMRN vs DTSS Comparison

IMRN vs DTSS Comparison

Compare IMRN & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • DTSS
  • Stock Information
  • Founded
  • IMRN 1994
  • DTSS 2014
  • Country
  • IMRN Australia
  • DTSS China
  • Employees
  • IMRN N/A
  • DTSS N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • IMRN Health Care
  • DTSS Technology
  • Exchange
  • IMRN Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • IMRN 15.0M
  • DTSS 14.2M
  • IPO Year
  • IMRN N/A
  • DTSS N/A
  • Fundamental
  • Price
  • IMRN $1.90
  • DTSS $2.33
  • Analyst Decision
  • IMRN Strong Buy
  • DTSS
  • Analyst Count
  • IMRN 1
  • DTSS 0
  • Target Price
  • IMRN $5.00
  • DTSS N/A
  • AVG Volume (30 Days)
  • IMRN 4.7K
  • DTSS 325.5K
  • Earning Date
  • IMRN 03-03-2025
  • DTSS 02-13-2025
  • Dividend Yield
  • IMRN N/A
  • DTSS N/A
  • EPS Growth
  • IMRN N/A
  • DTSS N/A
  • EPS
  • IMRN N/A
  • DTSS N/A
  • Revenue
  • IMRN $3,271,194.00
  • DTSS $47,284,153.00
  • Revenue This Year
  • IMRN N/A
  • DTSS N/A
  • Revenue Next Year
  • IMRN N/A
  • DTSS N/A
  • P/E Ratio
  • IMRN N/A
  • DTSS N/A
  • Revenue Growth
  • IMRN 171.67
  • DTSS 117.51
  • 52 Week Low
  • IMRN $1.65
  • DTSS $1.65
  • 52 Week High
  • IMRN $5.96
  • DTSS $13.20
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 43.76
  • DTSS 56.71
  • Support Level
  • IMRN $1.89
  • DTSS $2.24
  • Resistance Level
  • IMRN $2.05
  • DTSS $2.40
  • Average True Range (ATR)
  • IMRN 0.08
  • DTSS 0.24
  • MACD
  • IMRN -0.02
  • DTSS 0.03
  • Stochastic Oscillator
  • IMRN 3.85
  • DTSS 48.62

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: